- Home
- MVST vs EMBC Comparison
MVST vs EMBC Comparison
Compare MVST & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVST
- EMBC
- Stock Information
- Founded
- MVST 2006
- EMBC 1924
- Country
- MVST United States
- EMBC United States
- Employees
- MVST N/A
- EMBC N/A
- Industry
- MVST Industrial Machinery/Components
- EMBC Medical/Dental Instruments
- Sector
- MVST Miscellaneous
- EMBC Health Care
- Exchange
- MVST Nasdaq
- EMBC Nasdaq
- Market Cap
- MVST 848.0M
- EMBC 788.4M
- IPO Year
- MVST N/A
- EMBC N/A
- Fundamental
- Price
- MVST $2.56
- EMBC $14.96
- Analyst Decision
- MVST Strong Buy
- EMBC Buy
- Analyst Count
- MVST 1
- EMBC 2
- Target Price
- MVST $6.00
- EMBC $19.00
- AVG Volume (30 Days)
- MVST 7.3M
- EMBC 660.6K
- Earning Date
- MVST 08-11-2025
- EMBC 08-08-2025
- Dividend Yield
- MVST N/A
- EMBC 4.01%
- EPS Growth
- MVST N/A
- EMBC 18.26
- EPS
- MVST N/A
- EMBC 1.42
- Revenue
- MVST $422,605,000.00
- EMBC $1,102,500,000.00
- Revenue This Year
- MVST $25.36
- EMBC N/A
- Revenue Next Year
- MVST $30.46
- EMBC N/A
- P/E Ratio
- MVST N/A
- EMBC $10.53
- Revenue Growth
- MVST 20.84
- EMBC N/A
- 52 Week Low
- MVST $0.15
- EMBC $9.20
- 52 Week High
- MVST $4.72
- EMBC $21.48
- Technical
- Relative Strength Index (RSI)
- MVST 40.50
- EMBC 72.03
- Support Level
- MVST $2.53
- EMBC $14.08
- Resistance Level
- MVST $2.69
- EMBC $14.82
- Average True Range (ATR)
- MVST 0.15
- EMBC 0.50
- MACD
- MVST 0.01
- EMBC -0.02
- Stochastic Oscillator
- MVST 30.00
- EMBC 99.38
About MVST Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extends from core battery chemistry to battery packs.
About EMBC Embecta Corp.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.